Biogen Pharmachem Industries Limited (BOM:531752)

BOM:531752 Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	-	-	-	24.74	16.23
Other Revenue	-	7.89	2.5	0.07	-
Revenue	-	7.89	2.5	24.81	16.23
Revenue Growth (YoY)	-	215.26%	-89.91%	52.90%	-
Cost of Revenue	-	-	-	20.15	14.81
Gross Profit	-	7.89	2.5	4.66	1.42
Selling, General & Admin	1.68	0.84	1.75	0.54	0.14
Other Operating Expenses	9.63	3.67	2.72	1.08	1.23
Operating Expenses	11.31	4.51	4.46	1.62	1.37
Operating Income	-11.31	3.38	-1.96	3.04	0.05
Other Non Operating Income (Expenses)	8.38	-	-	-	-0
EBT Excluding Unusual Items	-2.93	3.38	-1.96	3.04	0.05
Gain (Loss) on Sale of Investments	-	-	-	-3.12	-16.08
Gain (Loss) on Sale of Assets	-	15.92	6.63	-	-
Pretax Income	-2.93	19.31	4.67	-0.09	-16.03
Income Tax Expense	-	-	0.11	-	-
Net Income	-2.93	19.31	4.56	-0.09	-16.03
Net Income to Common	-2.93	19.31	4.56	-0.09	-16.03
Net Income Growth	-	323.86%	-	-	-
Shares Outstanding (Basic)	589	653	653	653	653
Shares Outstanding (Diluted)	589	653	653	653	653
Shares Change (YoY)	-9.76%	-	-	-	-
EPS (Basic)	-0.00	0.03	0.01	-0.00	-0.02
EPS (Diluted)	-0.00	0.03	0.01	-0.00	-0.02
EPS Growth	-	323.90%	-	-	-
Gross Margin	-	100.00%	100.00%	18.79%	8.75%
Operating Margin	-	42.87%	-78.19%	12.24%	0.31%
Profit Margin	-	244.67%	181.98%	-0.35%	-98.80%
EBIT	-11.31	3.38	-1.96	3.04	0.05
EBIT Margin	-	42.87%	-78.19%	12.24%	0.31%
Effective Tax Rate	-	-	2.42%	-	-
Revenue as Reported	8.38	23.82	9.13	24.81	16.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.